(Q44722857)

English

Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

fibrin degradation product

0 references

author name string

Mark Schneider

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Nicole Brufatto

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Erin Neill

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Michael Nesheim

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

8 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

13340-13345

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

On the Kinetics of the Reaction between Human Antiplasmin and Plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

On the Kinetics of the Reaction between Human Antiplasmin and a Low-Molecular-Weight Form of Plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Activation and characterization of procarboxypeptidase B from human plasma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

A kinetic analysis of the tissue plasminogen activator and DSPAalpha1 cofactor activities of untreated and TAFIa-treated soluble fibrin degradation products of varying size

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

The use of prothrombin(S525C) labeled with fluorescein to directly study the inhibition of prothrombinase by antithrombin during prothrombin activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M313211200

21 January 2018

Identifiers

10.1074/JBC.M313211200

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44722857&oldid=2034600561"